Back to results
US 2011/0212454 A1Published application
Assay for Telomerase Activity
AssigneeGeron Corporation
InventorZhu Zhen Pirot
Life of this patent
Estimating the term…
Abstract
The invention is directed to methods for determining the level of telomerasc reverse transcriptase activity in mammalian cells.
Claims23
A method for detecting a presence or an amount of telomerase activity, comprising:
- (a) combining in a reaction vessel (1) an active telomerase ribonucleoprotein enzyme complex bound to a solid support by an anti-telomerase antibody, (2) a first primer, which is suitable as a telomerase substrate, and (3) a plurality of nucleoside triphosphates to form a reaction mixture, and incubating the reaction mixture under conditions to extend the first primer to produce an extension product;
- and (b) qualitatively or quantitatively detecting the extension product and correlating the detection with the presence or amount of telomerase activity.
A method for detecting a presence or an amount of telomerase activity, comprising:
- (a) binding an active telomerase ribonucleoprotein enzyme complex to a solid support with an antibody specific for the telomerase ribonucleoprotein enzyme complex,
- (a) combining in a reaction vessel (1) telomerase ribonucleoprotein enzyme complex bound to the solid support, (2) a first primer, which is suitable as a telomerase substrate, and (3) a plurality of nucleoside triphosphates to form a reaction mixture, and incubating the reaction mixture under conditions to extend the first primer to produce an extension product;
- and
- (b) qualitatively or quantitatively detecting the extension product and correlating the detection with the presence or amount of telomerase activity
1 more element
A method for evaluating the biological response of a mammalian biological system exposed to a telomerase modulator comprising:
- (a) combining in a reaction vessel (1) an active telomerase ribonucleoprotein enzyme complex from the biological system bound to a solid support by an anti-telomerase antibody, (2) a first primer, which is suitable as a telomerase substrate, and (3) a plurality of nucleoside triphosphates to form a reaction mixture, and incubating the reaction mixture under conditions to extend the first primer to produce an extension product;
- and
- (b) qualitatively or quantitatively detecting the extension product and correlating the amount of extension product with the amount of telomerase activity;
- (c) comparing the level of telomerase activity after administration of the modulator to the standard telomerase activity to determine the biological response of the subject.
1 more element
Dependencies are inferred from the claim text.